Yazici Y, McAlindon TE, Gibofsky A, et al. Radiographic outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, WNT pathway inhibitor (SM04690) in the treatment of osteoarthritis of the knee: week 26 interim analysis. EULAR 2017, #OP0166.
Tijdelijke opheffing sluis voor ravulizumab en toepassing sluis op glofitamab en bimekizumab
jul 2023 | Lymfoom, Spondyloartritis